Review



cd73 inhibited apoevs  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress cd73 inhibited apoevs
    ApoEVs hydrolyze ATP to adenosine via surface CD39 and <t>CD73.</t> ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.
    Cd73 Inhibited Apoevs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd73 inhibited apoevs/product/MedChemExpress
    Average 94 stars, based on 11 article reviews
    cd73 inhibited apoevs - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis"

    Article Title: T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis

    Journal: International Journal of Nanomedicine

    doi: 10.2147/IJN.S491222

    ApoEVs hydrolyze ATP to adenosine via surface CD39 and CD73. ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.
    Figure Legend Snippet: ApoEVs hydrolyze ATP to adenosine via surface CD39 and CD73. ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.

    Techniques Used: Activity Assay, In Vitro, Concentration Assay, Western Blot, Membrane, Immuno-Electron Microscopy

    ApoEVs promote bone regeneration via surface CD39 and CD73. OVX mice were divided into four groups and injected with PBS, ApoEVs, and POM or PSB pretreated ApoEVs, respectively (N = 5–6). Extracellular ATP ( A ) and adenosine ( B ) concentration in bone marrow plasma in different groups of mice were detected. ( C ) Micro-CT analyses of trabecular bone mass in the femurs. ( D-G ) Quantitative analyses of BMD ( D ), BV/TV ( E ), Tb. N ( F ) and Tb. Sp ( G ). ( H-J ) ELISA assays of IFN-γ ( H ), IL-17 ( I) and TNF-α ( J ) concentrations in the serum of peripheral blood from indicated groups. Data are presented as mean ± SD; ns, not significant; *P< 0.05; **P< 0.01; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test.
    Figure Legend Snippet: ApoEVs promote bone regeneration via surface CD39 and CD73. OVX mice were divided into four groups and injected with PBS, ApoEVs, and POM or PSB pretreated ApoEVs, respectively (N = 5–6). Extracellular ATP ( A ) and adenosine ( B ) concentration in bone marrow plasma in different groups of mice were detected. ( C ) Micro-CT analyses of trabecular bone mass in the femurs. ( D-G ) Quantitative analyses of BMD ( D ), BV/TV ( E ), Tb. N ( F ) and Tb. Sp ( G ). ( H-J ) ELISA assays of IFN-γ ( H ), IL-17 ( I) and TNF-α ( J ) concentrations in the serum of peripheral blood from indicated groups. Data are presented as mean ± SD; ns, not significant; *P< 0.05; **P< 0.01; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test.

    Techniques Used: Injection, Concentration Assay, Micro-CT, Enzyme-linked Immunosorbent Assay



    Similar Products

    cd73 inhibited apoevs  (MedChemExpress)
    94
    MedChemExpress cd73 inhibited apoevs
    ApoEVs hydrolyze ATP to adenosine via surface CD39 and <t>CD73.</t> ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.
    Cd73 Inhibited Apoevs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd73 inhibited apoevs/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cd73 inhibited apoevs - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    ApoEVs hydrolyze ATP to adenosine via surface CD39 and CD73. ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.

    Journal: International Journal of Nanomedicine

    Article Title: T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis

    doi: 10.2147/IJN.S491222

    Figure Lengend Snippet: ApoEVs hydrolyze ATP to adenosine via surface CD39 and CD73. ( A ) The activity of ApoEVs and apoptotic T cells to hydrolyze ATP was measured in vitro (N = 3). ( B ) Extracellular ATP concentration in bone marrow plasma of sham and OVX animals (N = 6). ( C ) Western blot analysis of CD39 and CD73 in bone marrow of sham and OVX animals. ( D ) Extracellular adenosine concentration in bone marrow plasma of sham and OVX animals. ( E ) Western blot analysis of CD39 and CD73 on the membrane of apoptotic T cells and ApoEVs. ( F ) Immunoelectron microscopy detection of CD39 and CD73 on ApoEVs (scale bar = 200 nm). Yellow arrows indicate CD39 and red arrows indicate CD73 adhered by gold particles. ( G ) The activity of ApoEVs to hydrolyze ATP with or without POM (a CD39 inhibitor) or PSB (a CD73 inhibitor) was determined in vitro (N = 3). ( H ) The activity of ApoEVs in hydrolyzing ATP to adenosine with or without POM or PSB was determined in vitro (N = 3). Data are presented as mean ± SD; ns, not significant; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test or unpaired Student’s t test.

    Article Snippet: To prepare CD39- or CD73-inhibited ApoEVs, 30 μg/mL of ApoEVs were preincubated with 100 μM POM (dissolved in DMSO, MedChemExpress) or PSB (dissolved in water, MedChemExpress) for 40 minutes at room temperature.

    Techniques: Activity Assay, In Vitro, Concentration Assay, Western Blot, Membrane, Immuno-Electron Microscopy

    ApoEVs promote bone regeneration via surface CD39 and CD73. OVX mice were divided into four groups and injected with PBS, ApoEVs, and POM or PSB pretreated ApoEVs, respectively (N = 5–6). Extracellular ATP ( A ) and adenosine ( B ) concentration in bone marrow plasma in different groups of mice were detected. ( C ) Micro-CT analyses of trabecular bone mass in the femurs. ( D-G ) Quantitative analyses of BMD ( D ), BV/TV ( E ), Tb. N ( F ) and Tb. Sp ( G ). ( H-J ) ELISA assays of IFN-γ ( H ), IL-17 ( I) and TNF-α ( J ) concentrations in the serum of peripheral blood from indicated groups. Data are presented as mean ± SD; ns, not significant; *P< 0.05; **P< 0.01; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test.

    Journal: International Journal of Nanomedicine

    Article Title: T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis

    doi: 10.2147/IJN.S491222

    Figure Lengend Snippet: ApoEVs promote bone regeneration via surface CD39 and CD73. OVX mice were divided into four groups and injected with PBS, ApoEVs, and POM or PSB pretreated ApoEVs, respectively (N = 5–6). Extracellular ATP ( A ) and adenosine ( B ) concentration in bone marrow plasma in different groups of mice were detected. ( C ) Micro-CT analyses of trabecular bone mass in the femurs. ( D-G ) Quantitative analyses of BMD ( D ), BV/TV ( E ), Tb. N ( F ) and Tb. Sp ( G ). ( H-J ) ELISA assays of IFN-γ ( H ), IL-17 ( I) and TNF-α ( J ) concentrations in the serum of peripheral blood from indicated groups. Data are presented as mean ± SD; ns, not significant; *P< 0.05; **P< 0.01; ***P< 0.001 by one-way ANOVA with Tukey’s post hoc test.

    Article Snippet: To prepare CD39- or CD73-inhibited ApoEVs, 30 μg/mL of ApoEVs were preincubated with 100 μM POM (dissolved in DMSO, MedChemExpress) or PSB (dissolved in water, MedChemExpress) for 40 minutes at room temperature.

    Techniques: Injection, Concentration Assay, Micro-CT, Enzyme-linked Immunosorbent Assay